CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PRINT-CHEMO project focuses on improving osteosarcoma treatment in children by using localized delivery of nanoparticles carrying a tumor suppressive gene and chemotherapy. This innovative approach aims to enhance survival rates while minimizing side effects, and also promotes bone regeneration post-tumor removal.
Osteosarcoma is the most commonly diagnosed bone tumour with most of these cases being in children and adolescents.
Each year over 4,000 new cases of osteosarcoma are diagnosed in the United States.
Osteosarcoma predominantly initiates in the metaphysis of long bones, such as the distal femur, proximal tibia and proximal humerus.
Over 50% of these tumours are relatively resistant to radiation therapy, due to the molecular aberration of the tumour.
The current gold standard for treatment is tumou…
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Boston
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
